Signed in as:
- My Account
Signed in as:
RPLA has partnered with American Society for Reproductive Medicine (ASRM) Research Institute on a research award for investigators looking into causes of and treatments for recurrent miscarriage.
This annual award will total $40,000 for a two-year study period. The purpose of this grant is to support innovative research projects that provide insights into causes, diagnosis, management, or parthenogenesis of recurrent pregnancy loss.
Applicants must demonstrate a strong career goal within the field of Reproductive Medicine and must be dedicated to the advancement of reproductive health and recurrent pregnancy loss research. Research proposals can involve physiological, psychological, biochemical, pharmacological, genetic, environmental, or pathological investigations.
For more information on this and other ASRM funding opportunities click the button below.
Applicants must be actively working in areas related to reproductive medicine in the United States. The principal investigator (PI) must:
An award, not to exceed $40,000, will be made for a TWO (2) year study period.
An application must include:
An ASRM Research Institute Grant Review Group (GRG) in collaboration with the RPLA appointed designees, will review the proposals and an awardee determined. To avoid a potential conflict of interest, members of the GRG will recuse themselves from review of any proposal that involves their institutions of employment. Award notifications will be made in March 2023 and funding will be dispersed April 2023.
The project will have the following objectives:
The project will have the following deliverables:
Research progress and financial reports must be submitted to ASRM and RPLA annually; this should include an activity summary and review of current findings/results. A final research report is due within 60 days of the end date of the project period. The reporting requirements for the final report are the following: Lay Summary, Activity Summary, Impact, Budget Summary, Publications, Presentations, Data Sharing Plan, and Other Study Generated Findings.
Publications, abstracts, manuscripts and/or presentations at scientific conferences or meetings based on results from the funded project must acknowledge RPLA and ASRM using the following language: “Funded in part by a grant from the Recurrent Pregnancy Loss Association in partnership with the American Society for Reproductive Medicine.” Results and research findings must be presented at the ASRM Congress within two years of receiving the award and copy of any published works should be sent to the Board of Directors of RPLA and ASRM Research Institute.
The names of the Investigator and institution as well as the project title, a description of the project, and information regarding the award may be listed on the RPLA website (www.rplassociation.org), ASRM Research Institute website (https://www.asrmresearch.org ), social media pages, or in print & digital written materials.
Copyright © 2022 Recurrent Pregnancy Loss Association - All Rights Reserved.
Powered by GoDaddy Website Builder